netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 10: Musculoskeletal and joint diseases - Full Chapter
10.01.02.02  Expand sub section  Local corticosteroids injections
Betamethasone
(Local Injection)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary  
  • UCLH:
  • WH:
    • No restriction stated
 
Dexamethasone
(Local Injection)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated  
  • UCLH:
  • WH:
    • No restriction stated
 
Hydrocortisone acetate
(Local Injection)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated  
  • UCLH:
  • WH:
    • No restriction stated
 
Methylprednisolone acetate
(Depo-Medrone)
(Local Injection)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated 
  • UCLH:
  • WH:
    • No restriction stated
 
Methylprednisolone acetate + Lidocaine injection
(Depo-Medrone with Lidocaine)
(Local inflammation of joints and soft tissues)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated 
  • UCLH:
  • WH:
    • No restriction stated
 
Prednisolone acetate
(Local Injection)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Triamcinolone acetonide
(Adcortyl)
(Local Injection: Intra-articular/ Intradermal)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Triamcinolone acetonide
(Kenalog)
(Local Injection: Intra-articular/ Intramuscular)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Triamcinolone hexacetonide
(Local Injection)
View childrens BNF
Restricted Drug Restricted
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Restricted for paediatric use ONLY.
    • See additional notes below.
  • UCLH:
  • WH:
    • No restriction stated

Additional notes:

  • Ampoules must be inspected for discolouration of the contents prior to administration.
  • Shake gently before use.
  • If necessary, Triamcinolone Hexacetonide may be mixed with 1% or 2% lidocaine hydrochloride. It must be drawn into the syringe before drawing in the anaesthetic to prevent contamination. The syringe should then be shaken gently, and the resulting solution used immediately thereafter.
 
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Homecare
Homecare

Traffic Light Status Information

Status Description

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

See link for the complete NCL Red List https://www.ncl-mon.nhs.uk/wp-content/uploads/2017/08/ncl_red_list.pdf

  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary